BHC · Bausch Health Companies Inc.
$4.44
-0.01 (-0.22%)
At close · Jul 24
Market Cap
$1.65B
Shares
373.48M
Bausch Health Companies Inc. Earnings Call Transcripts
Every quarterly earnings call for Bausch Health Companies Inc. (BHC) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼6.3%
$1.97B
−$145.00M
'22 Q2
22-08-09
▼3.1%
$2.05B
$399.00M
'22 Q3
22-11-03
▼0.1%
$2.19B
−$410.00M
'22 Q4
23-02-23
▲1.4%
$1.94B
−$201.00M
'23 Q1
23-05-04
▲10.2%
$2.17B
$26.00M
'23 Q2
23-08-03
▲9.4%
$2.24B
−$378.00M
'23 Q3
23-11-02
▲9.8%
$2.41B
−$39.00M
'23 Q4
24-02-22
▲10.8%
$2.15B
−$64.00M
'24 Q1
24-05-02
▲10.9%
$2.40B
$10.00M
'24 Q2
24-08-01
▲12.2%
$2.51B
−$85.00M
'24 Q3
24-10-30
▲6.3%
$2.56B
$93.00M
'24 Q4
25-02-19
▲4.9%
$2.26B
−$58.00M
'25 Q1
25-04-30
▲5.3%
$2.53B
$148.00M
'25 Q2
25-07-30
▲6.8%
$2.68B
$179.00M
'25 Q3
25-10-29
▲9.3%
$2.80B
−$112.00M
'25 Q4
26-02-18
LATEST
▲11.7%
$2.52B
−$1.42B
'26 Q1
26-04-29
Earnings call
FY26 · Q1
2026-04-29
Bausch Health Companies Inc. Q1 FY2026 Earnings Call
Confident tone
Revenue and EBITDA growth
Salix / Xifaxan performance
Tariffs
Revenue
$2.52B
▲ 11.7% YoY Diluted EPS
$-3.82
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-18
Bausch Health Companies Inc. Q4 FY2025 Earnings Call
Positive tone
Revenue and EBITDA growth
Solta and aesthetics growth
Salix segment performance
Revenue
$2.80B*
▲ 9.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-29
Bausch Health Companies Inc. Q3 FY2025 Earnings Call
Confident tone
Raised full-year guidance
Salix / Xifaxan performance
Solta Medical growth and APAC dependency
Revenue
$2.68B
▲ 6.8% YoY Diluted EPS
$0.48
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-30
Bausch Health Companies Inc. Q2 FY2025 Earnings Call
Positive tone
Revenue and Adjusted EBITDA Growth
Salix / Xifaxan Performance
Solta and International Growth
Revenue
$2.53B
▲ 5.3% YoY Diluted EPS
$0.40
▲ 1233.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-30
Bausch Health Companies Inc. Q1 FY2025 Earnings Call
Confident tone
Revenue and EBITDA growth
Solta international growth
Xifaxan / Salix performance
Revenue
$2.26B
▲ 4.9% YoY Diluted EPS
$-0.16
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-19
Bausch Health Companies Inc. Q4 FY2024 Earnings Call
Confident tone
Revenue and EBITDA growth
Bausch + Lomb (BLCO) monetization
IRA price negotiation for Xifaxan
Revenue
$2.56B*
▲ 6.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-30
Bausch Health Companies Inc. Q3 FY2024 Earnings Call
Confident tone
Quarterly financial performance and guidance raise
XIFAXAN growth and lifecycle management
Solta medical aesthetics growth
Revenue
$2.51B
▲ 12.2% YoY Diluted EPS
$-0.23
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-01
Bausch Health Companies Inc. Q2 FY2024 Earnings Call
Positive tone
Xifaxan Franchise and IP Defense
Bausch + Lomb Separation
Solta Aesthetics Growth
Revenue
$2.40B
▲ 10.9% YoY Diluted EPS
$0.03
▼ 57.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Bausch Health Companies Inc. Q1 FY2024 Earnings Call
Positive tone
Quarterly Revenue and EBITDA Growth
Xifaxan IP and Litigation
IRS / Granite Trust Settlement
Revenue
$2.15B
▲ 10.8% YoY Diluted EPS
$-0.17
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-22
Bausch Health Companies Inc. Q4 FY2023 Earnings Call
Positive tone
2023 Results and 2024 Guidance
R&D Pipeline (Amiselimod, RED-C)
Salix Segment / Xifaxan Franchise
Revenue
$2.41B*
▲ 9.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-02
Bausch Health Companies Inc. Q3 FY2023 Earnings Call
Revenue
$2.24B
▲ 9.4% YoY Diluted EPS
$-1.03
▼ 193.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
Bausch Health Companies Inc. Q2 FY2023 Earnings Call
Revenue
$2.17B
▲ 10.2% YoY Diluted EPS
$0.07
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
Bausch Health Companies Inc. Q1 FY2023 Earnings Call
Revenue
$1.94B
▲ 1.4% YoY Diluted EPS
$-0.55
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-23
Bausch Health Companies Inc. Q4 FY2022 Earnings Call
Revenue
$2.19B*
▼ 0.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Bausch Health Companies Inc. Q3 FY2022 Earnings Call
Revenue
$2.05B
▼ 3.1% YoY Diluted EPS
$1.10
▲ 111.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
Bausch Health Companies Inc. Q2 FY2022 Earnings Call
Revenue
$1.97B
▼ 6.3% YoY Diluted EPS
$-0.40
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-28
Bausch Health Companies Inc. Q1 FY2022 Earnings Call
Revenue
$1.92B
▼ 5.4% YoY Diluted EPS
$-0.19
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-23
Bausch Health Companies Inc. Q4 FY2021 Earnings Call
Revenue
$2.20B*
▼ 0.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-02
Bausch Health Companies Inc. Q3 FY2021 Earnings Call
Revenue
$2.11B
▼ 1.3% YoY Diluted EPS
$0.52
▲ 160% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-03
Bausch Health Companies Inc. Q2 FY2021 Earnings Call
Revenue
$2.10B
▲ 26.2% YoY Diluted EPS
$-1.66
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
Bausch Health Companies Inc. Q1 FY2021 Earnings Call
Revenue
$2.03B
▲ 0.7% YoY Diluted EPS
$-1.71
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-01-13
Bausch Health Companies Inc. Q4 FY2020 Earnings Call
Revenue
$2.21B
▼ 0.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-03
Bausch Health Companies Inc. Q3 FY2020 Earnings Call
Revenue
$2.14B
▼ 3.2% YoY Diluted EPS
$0.20
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
Bausch Health Companies Inc. Q2 FY2020 Earnings Call
Revenue
$1.66B
▼ 22.7% YoY Diluted EPS
$-0.92
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Bausch Health Companies Inc. Q1 FY2020 Earnings Call
Revenue
$2.01B
▼ 0.2% YoY Diluted EPS
$-0.43
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–25 of 25 earnings calls
Key facts
CIK
885590
CUSIP
071734107
13F (30d)
27 filings
27 filers
Visit website
Investor relations